Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 15, 2023 - Issue
Submit an article Journal homepage
210
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease

Yan Song1 Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7566-2813View further author information
ORCID Icon,
Jian-Yu E1 Analysis Group, Inc, Boston, MA, USAView further author information
,
Tracy Guo1 Analysis Group, Inc, Boston, MA, USAView further author information
,
Rahul Sasane2 Cerevel Therapeutics, Cambridge, MA, USAView further author information
,
Steve Arcona2 Cerevel Therapeutics, Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0001-7926-5420View further author information
ORCID Icon,
Nirmal Keshava2 Cerevel Therapeutics, Cambridge, MA, USAView further author information
&
Eric Wu1 Analysis Group, Inc, Boston, MA, USAView further author information
 show all
Pages 631-643 | Received 19 May 2023, Accepted 25 Jul 2023, Published online: 02 Aug 2023

References

  • Collaborators GUND, Feigin VL, Vos T, et al. Burden of neurological disorders across the US from 1990–2017: a Global Burden of Disease study. JAMA Neurol. 2021;78(2):165–176. doi:10.1001/jamaneurol.2020.4152
  • Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670–1683. doi:10.1001/jama.2014.3654
  • de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–535. doi:10.1016/s1474-4422(06)70471-9
  • de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63(7):1240–1244. doi:10.1212/01.wnl.0000140706.52798.be
  • Massano J, Bhatia KP. Clinical approach to Parkinson’s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med. 2012;2(6):a008870. doi:10.1101/cshperspect.a008870
  • Jankovic J, Tan EK. Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):795–808. doi:10.1136/jnnp-2019-322338
  • Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3
  • Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR. Unmasking levodopa resistance in Parkinson’s disease. Mov Disord. 2016;31(11):1602–1609. doi:10.1002/mds.26712
  • Riederer P, Laux G. MAO-inhibitors in Parkinson’s Disease. Exp Neurobiol. 2011;20(1):1–17. doi:10.5607/en.2011.20.1.1
  • Song Z, Zhang J, Xue T, et al. Different catechol-o-methyl transferase inhibitors in Parkinson’s disease: a Bayesian network meta-analysis. Front Neurol. 2021;12:707723. doi:10.3389/fneur.2021.707723
  • Borovac JA. Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology. Yale J Biol Med. 2016;89(1):37–47.
  • Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 2014;174(12):1930–1933. doi:10.1001/jamainternmed.2014.5262
  • Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis. 2020;6(1):15. doi:10.1038/s41531-020-0117-1
  • Kaltenboeck A, Johnson SJ, Davis MR, et al. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(4):321–326. doi:10.1016/j.parkreldis.2011.11.015
  • Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson’s disease on elderly Medicare beneficiaries. Mov Disord. 2006;21(3):362–372. doi:10.1002/mds.20727
  • Rubenstein LM, DeLeo A, Chrischilles EA. Economic and health-related quality of life considerations of new therapies in Parkinson’s disease. PharmacoEconomics. 2001;19(7):729–752. doi:10.2165/00019053-200119070-00003
  • Albarmawi H, Zhou S, Shulman LM, et al. The economic burden of Parkinson disease among Medicare beneficiaries. J Manag Care Spec Pharm. 2022;28(4):405–414. doi:10.18553/jmcp.2022.28.4.405
  • Dahodwala N, Li P, Jahnke J, et al. Burden of Parkinson’s disease by severity: health care costs in the U.S. Medicare population. Mov Disord. 2021;36(1):133–142. doi:10.1002/mds.28265
  • U.S. Department of Health and Human Services. 45 CFR 46: pre-2018 requirements. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#46.101. Accessed October 16, 2020.
  • Houghton R, Boess F, Verselis L, et al. Treatment patterns in patients with incident Parkinson’s disease in the United States. J Parkinsons Dis. 2019;9(4):749–759. doi:10.3233/JPD-191636
  • Navaratnam P, Arcona S, Friedman HS, Leoni M, Sasane R. Levodopa treatment patterns in Parkinson’s disease: a retrospective chart review. Clin Park Relat Disord. 2022;6:100135. doi:10.1016/j.prdoa.2022.100135
  • Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147–152.
  • Tarazi W, Welch WP, Nguyen N, et al. Medicare beneficiary enrollment trends and demographic characteristics. The Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services; 2022. Available from: https://aspe.hhs.gov/sites/default/files/documents/f81aafbba0b331c71c6e8bc66512e25d/medicare-beneficiary-enrollment-ib.pdf. Accessed July 10, 2023.
  • Cerri S, Mus L, Blandini F. Parkinson’s disease in women and men: what’s the difference? J Parkinsons Dis. 2019;9(3):501–515. doi:10.3233/JPD-191683
  • Kalilani L, Friesen D, Boudiaf N, Asgharnejad M. The characteristics and treatment patterns of patients with Parkinson’s disease in the United States and United Kingdom: a retrospective cohort study. PLoS One. 2019;14(11):e0225723. doi:10.1371/journal.pone.0225723

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.